for 3 newly-issued ordinary shares at Baht 10 per share. The subscription and payment period for the newly-issued ordinary shares is 31 July 2018 – 20 December 2018. The second allotment of the

= the market price per share of the Company’s ordinary shares A = Number of paid-up ordinary shares B = New ordinary shares reserved for the exercise of CCET-WC BX = the amount of proceeds received less

Limited (“The Company”) would like to inform that the Board of Directors’ Meeting No.7/2019, held on December 20 2019, has passed the resolution on the disposal of ordinary shares of Gofive Co., Ltd

of Baht 10 per share are issued and allocated to existing shareholder entitled shares to be set on July 6, 2018 (the Record Date). The newly-issued ordinary shares will be allocated to the existing

ordinary shares on the Stock Exchange Of Thailand (the “SET”) (“Spin-Off Plan”) will take place after 1) EP has obtained the approval for offering newly issued share from the Office of the Securities and

issued ordinary shares of the Company, at the par value of THB 6.90 per share, to ACO I as repayment of the Net Trade Debt of USD 32,934,250, or equivalent to THB 1,136,535,345.40, under the debt to equity

after capital increase : 5,000,000 HKD  No. of shares purchased : 3,300 Ordinary shares  Price per share : HKD 100 per 1 Ordinary shares  Total value of the transaction : HKD 330,000 or Baht 1,421,805

transaction to invest in the common stock of BS Myco Biotech Company Limited that operate in the Biopharmaceutical products with purchase from Bangjak Green Energy Company Limited total 399,990 shares or 85.65

14,000,000 of its registered capital in order to have registered capital at THB 15,000,000 (as per details set out below). 2 For the acquisition of Leyland’s ordinary shares, the share purchase price was

21,801,000,000 newly issued ordinary shares of the Company, at the par value of THB 5 per share, to ACO I as repayment of the Net Trade Debt of USD 123,899,729, or equivalent to THB 4,275,683,281.33, under the